Literature DB >> 22754595

An Integrated Bioinformatics and Computational Biology Approach Identifies New BH3-Only Protein Candidates.

Robert G Hawley1, Yuzhong Chen, Irene Riz, Chen Zeng.   

Abstract

In this study, we utilized an integrated bioinformatics and computational biology approach in search of new BH3-only proteins belonging to the BCL2 family of apoptotic regulators. The BH3 (BCL2 homology 3) domain mediates specific binding interactions among various BCL2 family members. It is composed of an amphipathic α-helical region of approximately 13 residues that has only a few amino acids that are highly conserved across all members. Using a generalized motif, we performed a genome-wide search for novel BH3-containing proteins in the NCBI Consensus Coding Sequence (CCDS) database. In addition to known pro-apoptotic BH3-only proteins, 197 proteins were recovered that satisfied the search criteria. These were categorized according to α-helical content and predictive binding to BCL-xL (encoded by BCL2L1) and MCL-1, two representative anti-apoptotic BCL2 family members, using position-specific scoring matrix models. Notably, the list is enriched for proteins associated with autophagy as well as a broad spectrum of cellular stress responses such as endoplasmic reticulum stress, oxidative stress, antiviral defense, and the DNA damage response. Several potential novel BH3-containing proteins are highlighted. In particular, the analysis strongly suggests that the apoptosis inhibitor and DNA damage response regulator, AVEN, which was originally isolated as a BCL-xL-interacting protein, is a functional BH3-only protein representing a distinct subclass of BCL2 family members.

Entities:  

Year:  2012        PMID: 22754595      PMCID: PMC3384560          DOI: 10.2174/1874196701205010006

Source DB:  PubMed          Journal:  Open Biol J


  98 in total

Review 1.  Homeostatic functions of BCL-2 proteins beyond apoptosis.

Authors:  Nika N Danial; Alfredo Gimenez-Cassina; Daniel Tondera
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

2.  Phylogenomics of life-or-death switches in multicellular animals: Bcl-2, BH3-Only, and BNip families of apoptotic regulators.

Authors:  Abdel Aouacheria; Frédéric Brunet; Manolo Gouy
Journal:  Mol Biol Evol       Date:  2005-08-10       Impact factor: 16.240

3.  Structural definition of the F-actin-binding THATCH domain from HIP1R.

Authors:  Tom J Brett; Valerie Legendre-Guillemin; Peter S McPherson; Daved H Fremont
Journal:  Nat Struct Mol Biol       Date:  2006-01-15       Impact factor: 15.369

Review 4.  Helix capping.

Authors:  R Aurora; G D Rose
Journal:  Protein Sci       Date:  1998-01       Impact factor: 6.725

5.  HIP1, a human homologue of S. cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain.

Authors:  M A Kalchman; H B Koide; K McCutcheon; R K Graham; K Nichol; K Nishiyama; P Kazemi-Esfarjani; F C Lynn; C Wellington; M Metzler; Y P Goldberg; I Kanazawa; R D Gietz; M R Hayden
Journal:  Nat Genet       Date:  1997-05       Impact factor: 38.330

6.  Identification of dAven, a Drosophila melanogaster ortholog of the cell cycle regulator Aven.

Authors:  Sige Zou; Joy Chang; Leesa LaFever; Wangli Tang; Erika L Johnson; Jack Hu; Ronit Wilk; Henry M Krause; Daniela Drummond-Barbosa; Pablo M Irusta
Journal:  Cell Cycle       Date:  2011-03-15       Impact factor: 4.534

7.  A new Aven-ue to DNA-damage checkpoints.

Authors:  Atan Gross
Journal:  Trends Biochem Sci       Date:  2008-10-01       Impact factor: 13.807

8.  HIP1 and HIP1r stabilize receptor tyrosine kinases and bind 3-phosphoinositides via epsin N-terminal homology domains.

Authors:  Teresa S Hyun; Dinesh S Rao; Djenann Saint-Dic; L Evan Michael; Priti D Kumar; Sarah V Bradley; Ikuko F Mizukami; Katherine I Oravecz-Wilson; Theodora S Ross
Journal:  J Biol Chem       Date:  2004-01-19       Impact factor: 5.157

9.  A novel binding pocket of cyclin-dependent kinase 2.

Authors:  Hao Chen; Rachel Van Duyne; Naigong Zhang; Fatah Kashanchi; Chen Zeng
Journal:  Proteins       Date:  2009-01

10.  Nonsyndromic hearing impairment is associated with a mutation in DFNA5.

Authors:  L Van Laer; E H Huizing; M Verstreken; D van Zuijlen; J G Wauters; P J Bossuyt; P Van de Heyning; W T McGuirt; R J Smith; P J Willems; P K Legan; G P Richardson; G Van Camp
Journal:  Nat Genet       Date:  1998-10       Impact factor: 38.330

View more
  5 in total

1.  Aven recognition of RNA G-quadruplexes regulates translation of the mixed lineage leukemia protooncogenes.

Authors:  Palaniraja Thandapani; Jingwen Song; Valentina Gandin; Yutian Cai; Samuel G Rouleau; Jean-Michel Garant; Francois-Michel Boisvert; Zhenbao Yu; Jean-Pierre Perreault; Ivan Topisirovic; Stéphane Richard
Journal:  Elife       Date:  2015-08-12       Impact factor: 8.140

2.  The novel BH3 α-helix mimetic JY-1-106 induces apoptosis in a subset of cancer cells (lung cancer, colon cancer and mesothelioma) by disrupting Bcl-xL and Mcl-1 protein-protein interactions with Bak.

Authors:  Xiaobo Cao; Jeremy L Yap; M Karen Newell-Rogers; Chander Peddaboina; Weihua Jiang; Harry T Papaconstantinou; Dan Jupitor; Arun Rai; Kwan-Young Jung; Richard P Tubin; Wenbo Yu; Kenno Vanommeslaeghe; Paul T Wilder; Alexander D MacKerell; Steven Fletcher; Roy W Smythe
Journal:  Mol Cancer       Date:  2013-05-16       Impact factor: 27.401

Review 3.  Redefining the BH3 Death Domain as a 'Short Linear Motif'.

Authors:  Abdel Aouacheria; Christophe Combet; Peter Tompa; J Marie Hardwick
Journal:  Trends Biochem Sci       Date:  2015-11-03       Impact factor: 13.807

4.  Telomerase Reverse Transcriptase Contains a BH3-Like Motif and Interacts with BCL-2 Family Members.

Authors:  Young Jin; Long You; Hye Jeong Kim; Han-Woong Lee
Journal:  Mol Cells       Date:  2018-06-25       Impact factor: 5.034

5.  Alterations of the interactome of Bcl-2 proteins in breast cancer at the transcriptional, mutational and structural level.

Authors:  Simon Mathis Kønig; Vendela Rissler; Thilde Terkelsen; Matteo Lambrughi; Elena Papaleo
Journal:  PLoS Comput Biol       Date:  2019-12-11       Impact factor: 4.475

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.